Is serum retinol-binding protein 4 inversely correlated with disease severity of chronic hepatitis C?
Disease severity may limit the role of RBP4 as a predictor of IR in CHC.
AT-101 enhances gefitinib sensitivity in NSCLC with EGFR T790M mutations. The addition of AT-101 to gefitinib is a promising strategy to overcome EGFR TKIs resistance in NSCLC with EGFR T790M mutations.